Press release
Global Metabolomics Biomarker Market Research and Forecast 2018-2023
According to the OMR analysis, the global metabolomics biomarker market is growing at a significant rate during 2018-2023. Metabolomics are profiling of metabolites in biofluids, cells and tissues, which are routinely applied as a tool for biomarker discovery. Due to innovation and developments in informatics and analytical technologies, enables in expanding metabolomic analyses and to understand the systems-level effects of metabolites. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis and analyst insights.
Full report of global high metabolomics biomarker market is available at: https://www.omrglobal.com/industry-reports/metabolomics-biomarker-market/
Metabolomics enables in advance the current understanding, diagnosis and treatment of several health conditions, which includes cancer, cardiovascular and neurological disorder. It enables in identifying pathophysiological processes and mechanisms of disease and management of targeted disease. The metabolomics biomarkers in tissue samples or biopsies, categorize and stage the progression of cancers, which enables in making appropriate decisions for treatment. The extensive application of metabolomics biomarker in colorectal cancer detection is driving the metabolomics biomarker market. The abnormal growth of cells in colon or rectum causes colorectal cancer, which is third commonly diagnosed cancer. According to American cancer society, about 27,150 men and 23,110 women died from Colorectal cancer in 2017. It is estimated about 95,520 new cases of colon cancer and 39,910 cases of rectal cancer diagnosed in US.
The market on the basis of geography is divided among four major regions – North America, APAC, Europe, and Rest of the world. North America is expected to dominate the metabolomics biomarker market and have the highest market share during the forecast period 2018-2023. Due to high product commercialization rates, development in healthcare sector and increasing use of biomarkers in drug discovery and development enables in boosting metabolomics biomarker market. Asia-Pacific shows high growth rate in metabolomics biomarker market due to increasing demand for improved pharmaceutical products, which are generated from emerging economies such as India and China, are significant contributing in the growth of the market.
The report covers:
Comprehensive research methodology of global metabolomics biomarker market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global metabolomics biomarker market.
Insights about market determinants which are stimulating the global metabolomics biomarker market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
For related reports please visit: https://www.omrglobal.com/reports-category/biotechnology/
For more updates follow LinkedIn: www.linkedin.com/company/omr-global-research/
About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
Contact us
Orion Market Research Pvt Ltd
116, Shagun Arcade, Vijay Nagar Square
Indore – India- 452010
Email: info@omrglobal.com
India: +91-780-304-0404, +91-917-982-8694
Global: +1-646-755-7667
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Metabolomics Biomarker Market Research and Forecast 2018-2023 here
News-ID: 1342017 • Views: …
More Releases from Orion Market Research
Sleep Apnea Implants Market Is Expected To Exhibit Significant Growth Over 2031
The global sleep apnea implants market is anticipated to grow at a CAGR of 10.6% during the forecast period. The rising geriatric population creating demand for global sleep apnea implants market during the forecast period. As per the study conducted by European Respiratory Society, the obstructive sleep apnea is a common disorder in older people; 13%-32% of people over 65 yrs old are highly susceptible to sleep apnea. According to…
Radiofrequency ablation (RF) Devices Market Will Exhibit an Impressive Expansion …
The global radiofrequency ablation devices market is anticipated to grow at a CAGR of 1.5% during the forecast period. The new and innovative RF ablation devices to support minimally invasive surgeries are a key factor driving the growth of the global radiofrequency ablation devices market. The key companies across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, mergers and acquisitions, new product launches,…
Nasal Drug Delivery Market Is Expected To Exhibit Significant Growth Over 2031
The global nasal drug delivery market is anticipated to grow at a considerable CAGR of 5.5% during the forecast. The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to positively impact significant market growth.
A full report of Nasal…
Myocardial Infarction Market Is Expected To Exhibit Significant Growth Over 2031
The global myocardial infarction market is anticipated to grow at a CAGR of around 6.6% during the forecast period. Factors contributing to the growth of the myocardial infarction market include rising incidence rate of CVDs (cardiovascular diseases) and intake of high-level sugary food, which significantly boost the prevalence of CADs (coronary artery diseases). According to the American Heart Association estimates, CVD is the leading global cause of death and accounted…
More Releases for Metabolomics
Global metabolomics technology market, size, share and trends, analysis report b …
Orion Market Research (OMR) recently published a market research report on the global metabolomics technology market. The market is segmented on the basis of product & service and application. On the basis of product & services, the market is further segmented into metabolomics instruments and bioinformatics. Furthermore, metabolomics instruments are sub-segmented into chromatography, mass spectrometry, nuclear magnetic resonance spectroscopy, others (capillary electrophoresis, surface-based mass analysis).
Metabolomics is a study to identify…
Metabolomics Market Segmentation Analysis
A large pool of players with a robust presence points towards the high degree of competition in the global metabolomics.market Thermo Fisher, Biocrates Life Sciences, Agilent Technologies, Shimadzu, Human Metabolome Technologies, Waters, Metabolon, LECO, Bruker, and Bio-Rad Laboratories are some of the key companies leading this market, finds a new research report by Transparency Market Research (TMR).
Hitherto, these companies have relied upon innovation and product advancements for the growth of…
Global Metabolomics Market $1.4 Billion by 2021
The global metabolomics market is estimated to reach $1. 4 Billion in 2021, growing at a CAGR of 15.6% from 2017 to 2021, according to a market research report Metabolomics Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc.
The metabolomics market report estimates the market size (Revenue $million - 2014 to 2021) and key market segments based on detection and separation techniques used, its applications (biomarker discovery, clinical toxicology, drug…
Metabolomics Market: Future Demand and Growth Analysis
Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules and their interactions in a biological system are known as the metabolome. Metabolomics involves the study of substrates and products of metabolism, which are affected by genetic and environmental factors. With the increasing applications of metabolomics in life sciences, the demand is increasing gradually. Metabolomics is gaining more…
Metabolomics Market: Overview & Sector Analysis (2016 - 2024)
Biomarker discovery segment to be the largest share of the global metabolomics market
The global metabolomics market is segmented on the basis of metabolomics instruments, application, indication, and geography. On the basis of metabolomics instrument, the metabolomics market is segmented into separation technique and detection technique. The separation technique is further segmented into gas chromatography, capillary electrophoresis, high-performance liquid chromatography, and ultra-performance liquid chromatography. The detection technique is further segmented into…
Metabolomics Market : Future of Metabolomics Dependent on Biomarker Discovery an …
According to a new market report published by Transparency Market Research “Metabolomics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024”, the metabolomics market is anticipated to expand at a CAGR of 17.1% from 2016 to 2024 to reach USD 2,494.8 million by 2024.
Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules…
